ROCO
5398
Market cap23mUSD
Oct 08, Last price
15.30TWD
1D
2.00%
1Q
0.66%
Jan 2017
-63.48%
Name
Inalways Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Inalways Corporation, a Taiwanese enterprise, operates across two primary sectors: the production of electronic and power supply components, and medical biotechnology. Within its medical biotechnology division, the company provides a range of products, including health-related foods, medical devices, and both over-the-counter and prescription pharmaceuticals. Established in 1978, Inalways Corporation is headquartered in New Taipei City, Taiwan. The firm underwent a name change in July 2017, transitioning from its former identity as Liwei Industrial Co., Ltd.
Key people
Shijian Yue
Vice Chairman of the Board · since 2020
Zhenglin Chen
General Manager · since 2025
Jiefu Chen
Deputy General Manager, Head of Finance & Accounting · since 2025
Shufen Li
Deputy General Manager · since 2014
Chief Strategy Officer, Chief Executive Officer-Electronic Product Business Division · since 2018
Jinlong Xiao
Corporate Governance Officer · since 2023
Qingquan Chen
Director · since 1978
Bofa Chen
Director · since 2015
Zhifen Guo
Director · since 2013
Zhengyong Huang
Director · since 2015
Bomeng Li
Director · since 2014
Pinyi Lu
Director · since 2018
Chairman of the Board · since 2025
Deputy General Manager, Director · since 2011
Director · since 2021
Zhizhe Yan
Director · since 2023
Sida Lai
Independent Director · since 2020
Longyi Lin
Independent Director · since 2020
Independent Director · since 2020
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||